| AMPs | antimicrobial peptides |
| NMR | nuclear magnetic resonance |
| CD | circular dichroism |
| MIC | minimum inhibitory concentration |
| PKA | protein kinase A |
| RhoG | Ras homolog family member G |
| LPS | lipopolysaccharide |
| FDA | Food and Drug Administration |
| PLGA | poly (lactic-co-glycolic acid) |
| PEG | polyethylene glycol |
| PVA | polyvinyl alcohol |
| CS | chitosan |
| MIC | minimal inhibit concentration |
| GRAS | generally recognized as safe |
| GMP | glycomacropeptide |
| MBC | minimum bactericidal concentration |
| LNPs | lipid nanoparticles |
| HSPC | L-α-phosphatidylcholine |
| DPPG | 1,2-Dipalmitoyl-sn-glycero-3-phosphoglycerol |
| GMO | glyceryl monooleate |
| AZT | azithromycin |
| MRSA | methicillin-resistant Staphylococcus aureus |
| FBS | fetal bovine serum |
| PAO | plasma amine oxidase |
| ODEX | oxidized dextran |
| PRP | platelet-rich plasma |
| SBMA | sulfonate betaine ester |
| AAc | acrylic acid |
| MNPs | metal-based nanoparticles |
| AuNPs | gold nanoparticles |
| AgNPs | silver nanoparticles |
| OA1 | Odorranain-A-OA1 |
| CMCS/SA | chitosan/sodium alginate |
| R2AW | ranatuerin-2-AW |
| CAD | computer-aided design |
| SVM | Support Vector Machines |
| MDR | multidrug-resistant |
| VRE | vancomycin-resistant Enterococcus |
| HA | hydroxyapatite |
| hBD-3 | β-defensin-3 |
| hBD-4 | β-defensin-4 |
| PEI | polyethyleneimine |
| PLL | poly (L-lysine) |
| AMR | antimicrobial resistance |
| G+ | Gram-positive |
| G− | Gram-negative |